You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Adoptive Cell Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Metastatic Urothelial Carcinoma Trial in Ramat Gan (Tumor Infiltrating Lymphocytes (TIL), Proleukin)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Ramat Gan, Israel
    Sheba Medical Center
Feb 8, 2021

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

Glioblastoma Multiforme Trial in Shanghai (TIL, PD1-TIL)

Active, not recruiting
  • Glioblastoma Multiforme
  • Shanghai, Shanghai, China
    Huashan hospital, Fudan University
Aug 24, 2021

B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

Active, not recruiting
  • B Cell Leukemia
  • Autologous CD19 CAR+ EGFTt + T cells
  • Seattle, Washington
    Seattle Children's Hospital
Feb 15, 2022

Melanoma, Melanoma, Uveal, Head Neck Cancer Trial in Rotterdam (Adoptive therapy with autologous MC2 TCR T cells)

Recruiting
  • Melanoma
  • +2 more
  • Adoptive therapy with autologous MC2 TCR T cells
  • Rotterdam, Netherlands
    Erasmus Medical Center
Jun 1, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
Has Results
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

Not yet recruiting
  • Lupus Nephritis
  • Type 1 Diabetes Mellitus
  • autologous adoptive T regulatory cell transfer.
  • Cairo, Egypt
    Ain shams university, faculty of medicine
Sep 30, 2022

Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
Jan 31, 2022

Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

Recruiting
  • Pancreatic Cancer
  • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
  • Shanghai, China
    Changhai Hospital affiliated to Naval Medical University
Mar 13, 2023

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

Suspended
  • Solid Tumor
  • NeoTCR-P1 adoptive cell therapy
  • +2 more
  • Duarte, California
  • +8 more
Aug 16, 2022

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

Recruiting
  • Gastric Cancer
  • +9 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Fludarabine + Cyclophosphamide combination
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

Recruiting
  • Multiple Sclerosis
  • Cellular therapy with EBV specific autologous CTL infusion
  • Nantes, France
    University Hospital
Jan 27, 2021

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

Recruiting
  • Neuroblastoma
  • Diffuse Intrinsic Pontine Glioma
  • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
  • Gainesville, Florida
  • +1 more
Apr 20, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Hepatocellular Carcinoma Trial in Beijing (adoptive immunotherapy, MWA)

Completed
  • Hepatocellular Carcinoma
  • adoptive immunotherapy
  • MWA
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 2, 2021

Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

Not yet recruiting
  • Advanced Melanoma
  • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
  • Basel, Switzerland
    University Hospital Basel
May 19, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Peripheral Blood Mononuclear Cells From Healthy People for

Recruiting
  • Healthy Volunteer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

    Not yet recruiting
    • Cancer
      • (no location specified)
      Feb 7, 2023